《2024ACC专家共识决策路径:射血分数降低心力衰竭治疗》解读
Interpretation about"2024 ACC Expert Consensus Decision Pathway:Treatment of Heart Failure with Reduced Ejection Fraction"
苑海涛 1杨乐1
作者信息
- 1. 山东省立医院心内科(济南,250021)
- 折叠
摘要
本文解读了《2024 ACC专家共识决策路径:射血分数降低心力衰竭治疗》的重点内容,着重分析了射血分数降低心力衰竭的"4大支柱"药物治疗方案.指南强调了早期和快速启动这些药物的重要性,以改善治疗效果、减少住院次数和降低死亡风险.
Abstract
This article interprets the key points of the"2024 ACC Expert Consensus Decision Pathway:Treatment of Heart Failure with Reduced Ejection Fraction(HFrEF)".It focuses on the"four pillars"of pharma-cotherapy for HFrEF,emphasizing the importance of early and rapid initiation of these medications to improve treatment outcomes,reduce hospitalizations,and decrease mortality risk.
关键词
射血分数降低心力衰竭/解读/治疗Key words
heart failure with reduced ejection fraction/interpretation/treatment引用本文复制引用
出版年
2024
NETL
NSTL
万方数据